• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by Xylo Technologies Ltd.

    6/23/25 7:20:44 AM ET
    $XYLO
    Medical/Dental Instruments
    Health Care
    Get the next $XYLO alert in real time by email
    6-K 1 ea0246509-6k_xylo.htm REPORT OF FOREIGN PRIVATE ISSUER

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 6-K

     

    REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

     

    For the month of June 2025

     

    Commission File Number 001-37381

     

    XYLO TECHNOLOGIES LTD.

    (Translation of registrant’s name into English)

     

    10 HaNechoshet Street Tel-Aviv, 6971072, Israel

    (Address of principal executive offices)

     

    Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

     

    Form 20-F ☒         Form 40-F ☐

     

     

     

     

    EXPLANATORY NOTE

     

    Xylo Technologies Ltd. (the “Company”) hereby announces that on June 22, 2025, the district court of Tel Aviv (Economic Division) (the “Court”) approved the arrangement (the “Arrangement”) between the Company and its shareholders, pursuant to Section 350 of the Israeli Companies Law, 5759-1999 and the regulations promulgated thereunder. The Arrangement was previously approved by the Company’s shareholders at special general meetings held on May 27, 2025. The Court has mandated that the Arrangement be consummated within 180 days of June 22, 2025.

     

    Following the Court’s approval, the Company expects to consummate the Arrangement in accordance with the terms previously disclosed. Upon consummation of the Arrangement, the Company will become a wholly-owned subsidiary of L.I.A. Pure Capital Ltd. (the “Applicant”), as the Applicant will purchase all of the issued and outstanding share capital of the Company that it does not already own. As a result, the Company’s American Depositary Shares will be delisted from the Nasdaq Stock Exchange, and its obligations as a public company will be terminated.

     

    The Company will update shareholders on the anticipated timeline for closing and any additional procedures as further information becomes available.

     

    Forward Looking Statement

     

    This Report of Foreign Private Issuer contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such words are intended to identify forward-looking statements. Because such statements deal with future events and are based on the Company’s current expectations, they are subject to various risks and uncertainties, and actual results, performance or achievements of the Company could differ materially from those described in or implied by the statements in this Report of Foreign Private Issuer on Form 6-K.

     

    The forward-looking statements contained or implied in this Report of Foreign Private Issuer on Form 6-K are subject to other risks and uncertainties, including those discussed in any filings with the SEC. Except as otherwise required by law, the Company undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

     

    This Form 6-K is incorporated by reference into the Company’s Registration Statements on Form F-3 (File No. 333-271984) and Form S-8 (File No. 333-274190, File No. 333-258624, File No. 333-206803, No. 333-221019 and No. 333-229429).

     

    1

     

    SIGNATURE

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

      XYLO TECHNOLOGIES LTD.
         
    Date: June 23, 2025 By: /s/ Tali Dinar
        Tali Dinar
        Chief Financial Officer

     

     

    2

     

    Get the next $XYLO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $XYLO

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $XYLO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Xylo Technologies: Viewbix Shares to Begin Trading on Nasdaq

    TEL AVIV, Israel, June 05, 2025 (GLOBE NEWSWIRE) -- Xylo Technologies Ltd. (NASDAQ:XYLO) ("Xylo" or the "Company"), a technology-based company engaged in advanced innovative technologies, announced today that Viewbix Inc. (NASDAQ:VBIX), a global developer of ad-tech innovative technologies, has received approval for its shares of common stock to be listed on the Nasdaq Capital Market. Viewbix, in which Xylo holds an indirect stake through its 45.74% ownership in Gix Internet Ltd. ("Gix Internet"), which in turn owns 2,818,585 common shares representing 42.58% of Viewbix, expects its shares to commence trading on Nasdaq under the symbol "VBIX" on or about June 5, 2025, subject to continued

    6/5/25 9:21:00 AM ET
    $MDGS
    $XYLO
    Medical/Dental Instruments
    Health Care

    Xylo Technologies: Charging Robotics Successfully Installs Wireless EV Charging System in Automatic Parking Facility

    TEL AVIV, Israel, April 30, 2025 (GLOBE NEWSWIRE) -- Xylo Technologies Ltd. (NASDAQ:XYLO) ("Xylo" or the "Company"), a technology-based company engaged in advanced innovative technologies, announced today that Charging Robotics, Inc. (OTC:CHEV) ("Charging Robotics"), a Delaware corporation (62.22% owned by Xylo), has successfully installed a system for wireless charging of electric vehicles with a leading supplier of robotic parking facilities.  Following the installation, the system successfully demonstrated the ability to wirelessly transfer power.  The system is intended to be used for charging electric vehicles ("EVs") while reporting charge data to the cloud and managing the charging

    4/30/25 9:12:00 AM ET
    $MDGS
    $XYLO
    Medical/Dental Instruments
    Health Care

    Xylo Technologies: Revoltz Secures First Institutional Client for PORTO EV Logistics Deployment

    TEL AVIV, Israel, April 29, 2025 (GLOBE NEWSWIRE) -- Xylo Technologies Ltd. (NASDAQ:XYLO) ("Xylo" or the "Company"), a technology-based company engaged in advanced innovative technologies, announced today that Revoltz Ltd. ("Revoltz"), which is 19.9% held by Charging Robotics, Inc. (OTC:CHEV) ("Charging Robotics"), a Delaware corporation quoted on the OTC Market (62.22% owned by Xylo), has secured its first institutional client for the PORTO EV, Revoltz's flagship electric micro-vehicle designed for last-mile logistics. The new order marks a significant step in Revoltz's commercial expansion strategy, transitioning from individual sales into larger fleet deployments. The institutional cus

    4/29/25 6:34:08 AM ET
    $MDGS
    $XYLO
    Medical/Dental Instruments
    Health Care

    $XYLO
    SEC Filings

    View All

    SEC Form EFFECT filed by Xylo Technologies Ltd.

    EFFECT - XYLO TECHNOLOGIES LTD (0001618500) (Filer)

    8/26/25 12:15:01 AM ET
    $XYLO
    Medical/Dental Instruments
    Health Care

    SEC Form 15-12G filed by Xylo Technologies Ltd.

    15-12G - XYLO TECHNOLOGIES LTD (0001618500) (Filer)

    8/22/25 4:00:04 PM ET
    $XYLO
    Medical/Dental Instruments
    Health Care

    SEC Form 25-NSE filed by Xylo Technologies Ltd.

    25-NSE - XYLO TECHNOLOGIES LTD (0001618500) (Subject)

    8/22/25 9:06:32 AM ET
    $XYLO
    Medical/Dental Instruments
    Health Care